Stegmann
Antonius J. H. Stegmann, Katwijk NL
Patent application number | Description | Published |
---|---|---|
20080220014 | Recombinant viral-based malaria vaccines - The present invention relates to novel vaccines against malaria infections, based on recombinant viral vectors, such as alpha viruses, adenoviruses or vaccinia viruses. The recombinant viral-based vaccines can be used to immunize against different | 09-11-2008 |
20100172928 | Recombinant viral-based malaria vaccines - The present invention relates to novel vaccines against malaria infections, based on recombinant viral vectors, such as alpha viruses, adenoviruses or vaccinia viruses. The recombinant viral-based vaccines can be used to immunize against different | 07-08-2010 |
20110150930 | Recombinant viral-based malaria vaccines - Described are vaccines against malarial infections, which are based on recombinant viral vectors, such as alpha viruses, adenoviruses, or vaccinia viruses. The recombinant viral-based vaccines can be used to immunize against different | 06-23-2011 |
20120082694 | Recombinant Viral-Based Malaria Vaccines - Described are vaccines against malarial infections, which are based on recombinant viral vectors, such as alpha viruses, adenoviruses, or vaccinia viruses. The recombinant viral-based vaccines can be used to immunize against different | 04-05-2012 |
Barbara J. Stegmann, Iowa City, IA US
Patent application number | Description | Published |
---|---|---|
20140057295 | ANTI-MULLERIAN HORMONE CHANGES IN PREGNANCY AND PREDICTION OF ADVERSE PREGNANCY OUTCOMES AND GENDER - The present invention provides for methods for evaluating the risk of an adverse pregnancy outcome in a subject and methods for treating subjects evaluated as being high risk. In some aspects, the present invention provides a method of evaluating the risk of an adverse pregnancy outcome in a subject, where if the subject does have an abnormal level of AMH as compared to a predetermined normal level the subject is more likely to have an adverse pregnancy outcome, and if the subject does not have an abnormal level of AMH the subject is less likely to have an adverse pregnancy outcome. In other aspects, the present invention provides a method of determining the gender of a fetus comprising obtaining information regarding the level of AMH in a sample from a pregnant subject. | 02-27-2014 |
Johannes Abraham Stegmann, Langerug ZA
Patent application number | Description | Published |
---|---|---|
20120169063 | PERMANENT MAGNET GENERATOR - A new configuration for a double-sided rotor, radial flux, air-cored, permanent magnet electric generator ( | 07-05-2012 |
Mikkel Bille Stegmann, Vanlose DK
Patent application number | Description | Published |
---|---|---|
20130039725 | OBJECT FEEDER SYSTEM - Disclosed is an object feeder system configured for arrangement in a three dimensional scanner, the system comprising: an object feeder scanning plate assembly comprising a number of tracks, wherein each track adapted to hold at least one object holder, wherein said tracks are configured to extend within the plate assembly from a parking area towards a scanning area, and where each object holder is configured for retaining an object to be scanned in the scanner for obtaining a three dimensional representation of the object, and wherein the object feeder system further comprises means for moving the at least one object holder in the at least one track. | 02-14-2013 |
20130218531 | 3D MODELING OF AN OBJECT USING TEXTURAL FEATURES - 3D modeling of an object using textural features. Disclosed is a method and a system for 3D modeling of a 3D object adapted to be inserted in or worn by a patient. The 3D modeling applies information of one or more features from an acquired 2D digital representation including textural data of the location where the 3D object is adapted to be arranged. | 08-22-2013 |
Robert Stegmann, Pretoria ZA
Patent application number | Description | Published |
---|---|---|
20110118649 | METHOD AND DEVICE FOR THE TREATMENT OF GLAUCOMA - The invention relates to a method and a device for treatment of glaucoma, wherein by means of an elongated catheter provided with a distal portion and a proximal portion, a tube-shaped implant is inserted and released in a Schlemm's canal with two opposite openings exposed by an incision and a folded up scleral flap. In a first phase, the distal portion inserted into the Schlemm's canal through the first opening, while a fluid or gaseous medium is injected at the same time, and exited through the second opening, which is, in circumferential direction, oppositely located. The implant detachably disposed at the protruding distal portion and, in a second phase, inserted, in circumferential direction, into the expanded Schlemm's canal up to the first opening. Subsequently, the distal portion, which protrudes from the first opening, is detached from the implant and, together with the catheter, removed. | 05-19-2011 |
20120010702 | OPHTHALMIC IMPLANT FOR TREATMENT OF GLAUCOMA - An implant is placed within Schlemm's canal of the eye and provides tension to the trabecular meshwork. The tension is continuous and increases the aqueous outflow without the necessity of administering cholinergic drugs to treat glaucoma. | 01-12-2012 |
Robert C. Stegmann, Pretoria ZA
Patent application number | Description | Published |
---|---|---|
20130331760 | IMPLANT FOR THE TREATMENT OF GLAUCOMA - The invention refers to a tube configured as an implant for insertion at least at one location into the exposed Schlemm's canal of an eye and which, for example, has been mechanically dilated. The elongated tube insertable into the Schlemm's canal includes a plurality openings that are arranged at the tube in axial direction distanced from each other by ring parts and that are in communication with the trabecular tissue the interior space of the tube and the aqueous humor veins of the episcleral vein system and further includes openings oriented in axial direction at a circular arc shaped segment corresponding to the cross section profile of the tube. To realize the natural trabecular aqueous humor drainage, the tube are inserted into the Schlemm's canal that either the openings in the segment are in communication with the aqueous humor veins or that segment with the openings are associated with the trabecular tissue. | 12-12-2013 |